Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celldex Therapeutics SVPs Engage In Heavy Transactions

TheMotleyFool 
0 0 12.01.26
Celldex Therapeutics SVPs Engage In Heavy TransactionsPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
 

On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.

Transaction value based on SEC Form 4 reported price ($29.09); post-Transaction value based on Dec. 4, 2025 market close ($29.09).

Continue reading


Source Fool.com

Celldex Therapeutics Stock

€36.32
-5.270%
Celldex Therapeutics took a tumble today and lost -€2.020 (-5.270%).
Our community is currently high on Celldex Therapeutics with 18 Buy predictions and 3 Sell predictions.
With a target price of 40 € there is a slightly positive potential of 10.13% for Celldex Therapeutics compared to the current price of 36.32 €.
Show more
Like: 0
CLDX
Share

Comments

Not a member yet? Sign up for free!